Skip to content

Digital social platform assists in the management of patients with osteopenia or osteoporosis to increase bone density:a randomized controlled trial

Digital social platform assists in the management of patients with osteopenia or osteoporosis to increase bone density:a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086071
Enrollment
Unknown
Registered
2024-06-24
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

The management group:1. Carry out osteoporosis popular science education, and the health management team regularly releases health popular science education content, including osteoporosis prevention
control group:There was no intervention, only follow-up

Sponsors

920th Hospital of Joint Logistic Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with fragility fracture of the hip; 2. Patients with vertebral fragility fractures. ; 3.Axial bone mineral density (BMD) or distal 1/3 of radius with T score =-2.5 by DXA; 4. Bone mineral density was defined as osteopenia (-2.5= T-score =-1.0) + fragility fracture of proximal humerus, pelvis, or distal forearm; 5. Simple bone mineral density measurement accord with osteopenia (2.5 ? T value ? - 1.0) of patients; 6.Age > 18 years old, regardless of gender, except pregnant women.

Exclusion criteria

Exclusion criteria: 1. Patients who were unwilling to participate in the trial, had poor compliance, and did not sign informed consent. 2. Patients judged by clinicians to be ineligible for participation (e.g., recent bereavement (within 3 months), Alzheimer's disease, or psychiatric conditions).

Design outcomes

Primary

MeasureTime frame
bone mineral density;

Secondary

MeasureTime frame
Proportion of participants with at least one hip fracture, any clinical fracture, or death;EQ-5D;VAS;MMAS-8;Serological markers of bone turnover;

Countries

china

Contacts

Public ContactHongbo Tan

920th Hospital of Joint Logistic Support Force

tantoo@163.com+86 131 1695 5623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026